COMMUNIQUÉS West-GlobeNewswire

Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit

06/03/2024 - 15:15

BERKELEY HEIGHTS, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on [...]

Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask

06/03/2024 - 15:05

Enhances sleep apnea therapy by combining the ease and comfort of an ultra-compact, under-the-nose full-face design with the effectiveness of a traditional over-the-nose full-face mask. Featuring the AdaptiSeal ™ [...]

ARS Pharmaceuticals to Participate in the Leerink Partners Global Biopharma Conference 2024

06/03/2024 - 15:01

SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe [...]

Bioxytran Announces Preprint of Shingles Case Study Showing Clearance Using a Topical Galectin-3 Antagonist

06/03/2024 - 15:00

50% Lesion clearance and regression of Herpes Zoster Neuralgia within 48 – 72 hours BOSTON, MASSACHUSETTS, March 06, 2024 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. ( BIXT ), (the “Company”), a clinical stage biotechnology [...]

HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology

06/03/2024 - 15:00

Southlake, TX, March 06, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology [...]

Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution

06/03/2024 - 15:00

-- Paving the way forward for the broader commercial availability of FemaSeed, an accessible, safe, and cost effective alternative to IVF -- -- Ongoing uncertainty following recent Alabama Supreme Court Ruling creates [...]

Johnson & Johnson submits application to the European Medicines Agency for DARZALEX® (daratumumab)-based quadruplet therapy for the treatment of patients with transplant-eligible, newly diagnosed multiple myeloma

06/03/2024 - 14:53

Submission supported by data from Phase 3 PERSEUS study, which showed the daratumumab subcutaneous formulation-based regimen significantly reduced the risk of progression or death, compared to standard of care regimen 1 [...]

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

06/03/2024 - 14:52

Please see enclosed pdf. Attachment 06032024_trading_in_shares_ASL

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

06/03/2024 - 14:50

Please see enclosed pdf. Attachment 06032024_trading_in_shares_KVI

SFWJ DBA MedCana Completes Acquisition of Two Additional Cannabis Companies, Solidifying Market Leadership

06/03/2024 - 14:45

AUSTIN, Texas, March 06, 2024 (GLOBE NEWSWIRE) -- Following its recent announcement, SFWJ DBA MedCana , a premier holding company in the cannabis industry, is delighted to confirm the successful acquisition of two [...]

Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients

06/03/2024 - 14:37

Clinical study evaluated impact of AVIM therapy as compared to standard pacing using invasive pressure-volume loop analysis in 16 hypertensive pacemaker-indicated patients Results demonstrate statistically significant [...]

CorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024

06/03/2024 - 14:30

BERKELEY HEIGHTS, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of [...]

Nexalin Technology Announces Positive Results from Clinical Study of its Gen-2 tACS Device for Treating Adult Patients with Chronic Insomnia

06/03/2024 - 14:30

Clinical study demonstrated clinically meaningful and statistically significant improvements in key sleep parameters, compared to adult patients treated with placebo Data published in Journal of Psychiatric Research [...]

Sofwave Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

06/03/2024 - 14:30

– Full fiscal 2023 revenue of $50.3M, +41% year-over-year growth; gross margin of 74. 5 % – F ull fiscal 2023 pulse recurring revenue of $ 13 .0 M, + 81 % year-over-year growth – Fourth quarter revenue of $15.3M, +11% [...]

Hepion Pharmaceuticals Strengthens Board of Directors with Appointment of Michael Purcell

06/03/2024 - 14:30

EDISON, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on therapeutic drug development for the treatment of non-alcoholic [...]

MiNK Announces Preclinical Data Showcasing Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR 2024

06/03/2024 - 14:30

MiNK-215 Eradicated Tumor Cells in Human Organoid MSS Colorectal Cancer Liver Metastases Model NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical [...]

Capricor Therapeutics Presents at 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

06/03/2024 - 14:30

Presentation Highlights Positive 24-Month Results from HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a [...]

Elicio Therapeutics Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting

06/03/2024 - 14:30

BOSTON, March 06, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the [...]

Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting

06/03/2024 - 14:30

Solutions for CROs, pharma and biotechs improve throughput and efficiency and enable future advancements in data analytics HOLLISTON, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) [...]